All < Article List

Will medical students and junior doctors return under President Lee Jae-myung?
Policy Kwak Sung-sun 06.04 11:21
HLB cancer combo shows survival gains in head and neck, spine, and NPC cancers
Bio Kim Ji-hye 06.04 11:21
SNUBH study finds colon cancer patients regain quality of life within 7 weeks after laparoscopic surgery
Hospital Lee Han-soo 06.04 11:20
EuBiologics wins WHO PQ for second oral cholera vaccine plant
Pharma Lee Han-soo 06.03 06:00
HLB’s liver cancer drug extends survival in phase 3 China study
Bio Kim Ji-hye 06.02 18:15
Amgen's Imdelltra wins Korean nod for tough-to-treat lung cancer
Pharma Kim Ji-hye 06.02 16:50
Merck Life Science Korea launches 2025 startup contest to foster next-generation biotech innovators
Bio Lee Han-soo 06.02 16:48
Yuhan collects $15 mil. as J&J lung cancer combo hits Japan
Pharma Kim Ji-hye 06.02 16:08
Faced with 50,000 petitions, Assembly to debate increasing access to cell and gene therapy
Policy Kim Eun-young 06.02 15:39
[ASCO 2025] Why can’t Korea also do it? KDDF head Park says
Pharma Hong Sook 06.02 14:57
KDCA urges Covid-19 vaccination for high-risk groups amid rising cases in neighboring countries
Policy Lee Han-soo 06.02 14:18
[ASCO 2025]Will the era of ‘PI3K’ targeted therapy open in HER2-positive breast cancer treatment?
Pharma Kim Yun-mi 06.02 14:10
NEXT BIOMEDICAL's embolic device Nexsphere-F joins US FDA’s TAP program
Device/ICT Lee Han-soo 06.02 14:01
[ASCO 2025] Anticancer giant AZ expands its therapeutic armamentarium with Camizestrant-Imfinzi
Pharma Hong Sook 06.02 13:39
Pfizer taps GC Biopharma to distribute Covid-19 pill in Korea
Pharma Kim Ji-hye 06.02 13:27
Health insurance subscribers’ dependents are down 15% for Korean subscribers while remaining same for foreigners
Policy Kim Eun-young 06.02 12:03
Samsung Bioepis gets Korean nod for biosimilar of Amgen’s bone drug Xgeva
Bio Kim Ji-hye 06.02 11:30
Government-doctor conflict continues on final days of Yoon administration
Policy Koh Jung Min 06.02 11:22
[ASCO 2025] Enhertu shows prolonged survival in 2nd-line treatment of gastric cancer
Pharma Kim Yun-mi 06.02 10:42
[ASCO 2025] Trodelvy could emerge as standard of care for triple-negative breast cancer
Pharma Kim Yun-mi 06.02 10:34

상단영역

본문영역

All articles 목록 ( 총 : 21,030 )

기사목록 보기 형태

Will medical students and junior doctors return under President Lee Jae-myung?

HLB cancer combo shows survival gains in head and neck, spine, and NPC cancers

SNUBH study finds colon cancer patients regain quality of life within 7 weeks after laparoscopic surgery

EuBiologics wins WHO PQ for second oral cholera vaccine plant

HLB’s liver cancer drug extends survival in phase 3 China study

Amgen's Imdelltra wins Korean nod for tough-to-treat lung cancer

Merck Life Science Korea launches 2025 startup contest to foster next-generation biotech innovators

Yuhan collects $15 mil. as J&J lung cancer combo hits Japan

Faced with 50,000 petitions, Assembly to debate increasing access to cell and gene therapy

[ASCO 2025] Why can’t Korea also do it? KDDF head Park says

KDCA urges Covid-19 vaccination for high-risk groups amid rising cases in neighboring countries

[ASCO 2025]Will the era of ‘PI3K’ targeted therapy open in HER2-positive breast cancer treatment?

NEXT BIOMEDICAL's embolic device Nexsphere-F joins US FDA’s TAP program

[ASCO 2025] Anticancer giant AZ expands its therapeutic armamentarium with Camizestrant-Imfinzi

Pfizer taps GC Biopharma to distribute Covid-19 pill in Korea

Health insurance subscribers’ dependents are down 15% for Korean subscribers while remaining same for foreigners

Samsung Bioepis gets Korean nod for biosimilar of Amgen’s bone drug Xgeva

Government-doctor conflict continues on final days of Yoon administration

[ASCO 2025] Enhertu shows prolonged survival in 2nd-line treatment of gastric cancer

[ASCO 2025] Trodelvy could emerge as standard of care for triple-negative breast cancer